RPL34P22

Across TCGA pan-cancer cohorts, RPL34P22 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPL34P22 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RPL34P22 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL34P22 expression acts as an unfavorable survival marker, although some lineages such as UCS and KIRC show a favorable association.

UCS, KIRC, and THCA are the cancer types where RPL34P22 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.628	0.269	.010	60	view →
KIRC	DFS	Median	III,IV	0.802	0.523	.006	39	view →
THCA	DFS	Tertile	All	0.887	0.958	.001	39	view →
LUAD	DFS	Median	All	0.735	0.613	.001	24	view →
LIHC	DFS	Tertile	All	0.581	0.273	.018	21	view →
HNSC	DFS	Tertile	II,III,IV	0.485	0.292	.004	18	view →
READ	DFS	Tertile	IV	0.112	0.811	.008	15	view →
SKCM	DFS	Quartile	IV	0.040	0.733	.008	12	view →
OV	DFS	Quartile	II,III,IV	0.441	0.361	.033	10	view →
KICH	OS	Tertile	II,III,IV	0.753	0.931	.035	9	view →
DLBC	DFS	Median	All	0.579	1.000	.007	8	view →
GBM	OS	Tertile	All	0.489	0.359	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPL34P22–UCS (OS)

Open the UCS breakdown →